Comment
Author: Admin | 2025-04-28
Assessment measurement system for rating symptoms before treatment begins. It’s repeated after the participants have taken medication (or placebo) for a certain length of time. One such measurement tool is the Hamilton Rating Scale for Depression (HRSD). In separate clinical trials, Cymbalta and Lexapro were similarly effective in reducing depression symptoms when compared to a placebo. Compared to a placebo, taking Cymbalta led to a 10- to 12-point improvement on a depression rating scale after two months of treatment. Similarly, taking Lexapro resulted in a reduction of 12 points compared to placebo after two months. A head-to-head clinical trial is a better way to measure the relative effectiveness of two medications. A few trials have compared Cymbalta and Lexapro for MDD. Here’s what these studies found: One trial compared Cymbalta and Lexapro for MDD. After eight weeks, participants who took Lexapro had a greater reduction in depression symptoms compared to those who took Cymbalta.Another study compared Cymbalta and Lexapro over an eight-month period. In this study, both medications led to similar improvements in depression symptoms. The only notable difference in the results was that Lexapro was better at improving sleep-related symptoms. Meta-analysis is another tool that can help researchers draw conclusions based on data from multiple individual studies. A 2018 meta-analysis reviewed various studies of Cymbalta and Lexapro to compare the two medications. Overall, the results suggest that Cymbalta and Lexapro are similarly effective in reducing depression symptoms.RecapUltimately, Lexapro and Cymbalta are similarly effective for treating depression. However, individual results
Add Comment